▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3980 by analyst upside · 2026-11-13
MTD
Mettler-Toledo International Inc.
Healthcare · Market Cap $34B · P/E 37.6x
ANALYST PRICE TARGET
+0.4%
implied upside to consensus target
Current Price $1730.93
Consensus Target $1737.5
Bull Target $1930.0
Bear Target $1200.0
Analysts Covering 12
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
4
Hold
6
Sell
1
52-Week Low $1023.05
52-Week High $1806.58
YTD Return +22.6%
FUNDAMENTALS
Market Cap $34B
P/E Ratio (TTM) 37.6x
Forward P/E 32.5x
EPS (TTM) $46.07
PEG Ratio 3.25
Dividend Yield N/A
Revenue (TTM) $4.2B
Profit Margin 22.2%
52-WEEK RANGE
52-Week Low $1023.05
52-Week High $1806.58
Current Price $1730.93
Bear Target $1200.0
Bull Target $1930.0
● Now $1730.93 ● Target $1737.5
TRADING DATA
Avg Volume 200K
YTD Return +22.6%
Analyst Count 12
Consensus Hold
Upside to Target +0.4%
Last Updated 2026-11-13

ANALYST SUMMARY

Mettler-Toledo International Inc. (MTD) is currently trading at $1730.93 with a Wall Street consensus price target of $1737.5, implying potential upside of 0.4% over the next 12 months. 12 analysts currently cover MTD, with a consensus rating of Hold - 42% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1930.0, while the most cautious has a target of $1200.0.

MTD operates in the Healthcare sector with a market capitalisation of $34B. The stock is up 22.6% year-to-date and is currently trading near the upper end of its 52-week range of $1023.05 – $1806.58.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

WST +14.5%
West Pharmaceutical Services, Inc.
$29B · P/E 46.2x · Buy
ILMN +24.8%
Illumina, Inc.
$32B · P/E 36.1x · Buy
IDXX +2.7%
IDEXX Laboratories, Inc.
$55B · P/E 47.0x · Buy
STE +10.9%
STERIS plc
$25B · P/E 30.1x · Buy
RPRX +4.4%
Royalty Pharma plc
$40B · P/E 45.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MTD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-10-13 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-07 Building track record
Rothschild & Co ● Initiated
Sell 2026-09-02 Building track record
RBC Capital ● Initiated
Sector Perform 2026-09-01 Building track record
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-08-04 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-08-03 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-08-03 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-08-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
49
out of 100
Coverage depth
20/30
Consensus clarity
22/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →